Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia
Go back to Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia| (NASDAQ: LRMR) | Delayed: 3.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.64 | 52 Week High | $ | |||
| Open | $3.64 | 52 Week Low | $ | |||
| Day High | $3.64 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $ | |||
| Volume | 6,376 | |||||
